Alkermes (ALKS) Income from Continuing Operations (2010 - 2026)
Alkermes' Income from Continuing Operations came in at $524,000 for Q2 2026, down 99.4% from $87.1 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Alkermes reported Income from Continuing Operations of $66.1 million, down 81.0% year-over-year; for FY2025, it came in at $241.66 million, down 35.1% from FY2024.
- Going back by year, Income from Continuing Operations was $372.14 million in FY2024 (-28.3%), $519.16 million in FY2023, -$33.15 million in FY2022 and $76.4 million in FY2021.
- The five-year range for quarterly Income from Continuing Operations is -$66.53 million (Q1 2026) to $279.1 million (Q2 2023).
- Year-over-year, Income from Continuing Operations increased in 1 of the last seven quarters, with an average decline of 33.5%.
- The fastest year-over-year change in Income from Continuing Operations over five years came in Q4 2023 (growth of 65.8%), and the weakest in Q2 2026 (a decline of 99.4%).
- Business Quant data shows ALKS's Income from Continuing Operations at -$66.53 million (Q1 2026), $49.34 million (Q4 2025) and $82.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Alkermes | 6.84 Bn | 3.97 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 524,000.00 |
| Mar 31, 2026 | -66.53 Mn |
| Dec 31, 2025 | 49.34 Mn |
| Sep 30, 2025 | 82.76 Mn |
| Jun 30, 2025 | 87.10 Mn |
| Mar 31, 2025 | 22.46 Mn |
| Dec 31, 2024 | 145.74 Mn |
| Sep 30, 2024 | 92.80 Mn |
| Jun 30, 2024 | 94.66 Mn |
| Mar 31, 2024 | 38.95 Mn |
| Dec 31, 2023 | 160.55 Mn |
| Sep 30, 2023 | 91.55 Mn |
| Jun 30, 2023 | 279.10 Mn |
| Mar 31, 2023 | -12.05 Mn |
| Dec 31, 2022 | 96.86 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 125.44 Mn |
| Sep 30, 2021 | -28.99 Mn |
API Access
Alkermes Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();